SCHEMBL7470290

SCHEMBL7470290

Cc1cc2nc(Cl)c(Cl)nc2c(N)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 1/20 0.35
ALDH1A1 P00352 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NR4A2 P43354 1/20 0.33
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
FABP6 P51161 1/20 0.32
GAA P10253 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
ACHE P22303 3/20 0.32
TERT O14746 1/20 0.31
TYMS P04818 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7478802 0.85 GRIN2D (0.35) MAPTKMT2ANR4A2TDP1ACHE
SCHEMBL7476392 0.85 ALDH1A1 (0.36) SMN1; SMN2MAPTCYP3A4CYP1A2CYP2D6
SCHEMBL23749957 0.74 TDP1 (0.40) SMN1; SMN2MAPTCYP3A4CYP1A2CYP2D6
SCHEMBL7470942 0.74 L3MBTL1 (0.37) SMN1; SMN2MAPTLMNAALDH1A1L3MBTL1
SCHEMBL6683153 0.72 TDP1 (0.34) CYP3A4ALDH1A1TDP1ACHE
SCHEMBL29472103 0.72 ADORA1 (0.37) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL22715518 0.72 ADORA1 (0.37) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL31530745 0.71 ALDH1A1 (0.56) SMN1; SMN2MAPTCYP3A4CYP1A2CYP2D6
SCHEMBL121241 0.71 ALDH1A1 (0.56) SMN1; SMN2MAPTCYP3A4CYP1A2CYP2D6
SCHEMBL5974306 0.71 NQO2 (0.59) SMN1; SMN2MAPTCYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5863917-A ANXIOLYTIC AGENT, ANTICONVULSANTS, ANALGESICS AND NEUROPROTECTIVES. PFIZER, INC. (US) 1999-01-26 US disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
WO-1997031902-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-04 WO disclosed
EP-0792874-A1 Quinoxaline derivatives useful in therapy Pfizer Limited (GB) 1997-09-03 EP disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed